272 related articles for article (PubMed ID: 35476049)
1. Sex and Race Differences in N-Terminal Pro-B-type Natriuretic Peptide Concentration and Absolute Risk of Heart Failure in the Community.
Myhre PL; Claggett B; Yu B; Skali H; Solomon SD; Røsjø H; Omland T; Wiggins KL; Psaty BM; Floyd JS; Selvin E; Ballantyne CM; Shah AM
JAMA Cardiol; 2022 Jun; 7(6):623-631. PubMed ID: 35476049
[TBL] [Abstract][Full Text] [Related]
2. Association of Long-term Change in N-Terminal Pro-B-Type Natriuretic Peptide With Incident Heart Failure and Death.
Jia X; Al Rifai M; Hoogeveen R; Echouffo-Tcheugui JB; Shah AM; Ndumele CE; Virani SS; Bozkurt B; Selvin E; Ballantyne CM; Nambi V
JAMA Cardiol; 2023 Mar; 8(3):222-230. PubMed ID: 36753229
[TBL] [Abstract][Full Text] [Related]
3. N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.
Ndumele CE; Matsushita K; Sang Y; Lazo M; Agarwal SK; Nambi V; Deswal A; Blumenthal RS; Ballantyne CM; Coresh J; Selvin E
Circulation; 2016 Feb; 133(7):631-8. PubMed ID: 26746175
[TBL] [Abstract][Full Text] [Related]
4. Racial differences in the association of NT-proBNP with risk of incident heart failure in REGARDS.
Patel N; Cushman M; Gutiérrez OM; Howard G; Safford MM; Muntner P; Durant RW; Prabhu SD; Arora G; Levitan EB; Arora P
JCI Insight; 2019 Jun; 5(13):. PubMed ID: 31162140
[TBL] [Abstract][Full Text] [Related]
5. N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of Atherosclerosis.
Choi EY; Bahrami H; Wu CO; Greenland P; Cushman M; Daniels LB; Almeida AL; Yoneyama K; Opdahl A; Jain A; Criqui MH; Siscovick D; Darwin C; Maisel A; Bluemke DA; Lima JA
Circ Heart Fail; 2012 Nov; 5(6):727-34. PubMed ID: 23032197
[TBL] [Abstract][Full Text] [Related]
6. High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.
Bansal N; Hyre Anderson A; Yang W; Christenson RH; deFilippi CR; Deo R; Dries DL; Go AS; He J; Kusek JW; Lash JP; Raj D; Rosas S; Wolf M; Zhang X; Shlipak MG; Feldman HI
J Am Soc Nephrol; 2015 Apr; 26(4):946-56. PubMed ID: 25278510
[TBL] [Abstract][Full Text] [Related]
7. N-terminal pro-B-type natriuretic peptide for prediction of ventricular arrhythmias: Data from the SMASH study.
Sourour N; Riveland E; Naesgaard P; Kjekshus H; Larsen AI; Omland T; Røsjø H; Myhre PL
Clin Cardiol; 2023 Aug; 46(8):989-996. PubMed ID: 37400982
[TBL] [Abstract][Full Text] [Related]
8. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
[TBL] [Abstract][Full Text] [Related]
9. Neither race nor gender influences the usefulness of amino-terminal pro-brain natriuretic peptide testing in dyspneic subjects: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
Krauser DG; Chen AA; Tung R; Anwaruddin S; Baggish AL; Januzzi JL
J Card Fail; 2006 Aug; 12(6):452-7. PubMed ID: 16911912
[TBL] [Abstract][Full Text] [Related]
10. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
[TBL] [Abstract][Full Text] [Related]
11. Optimal Screening for Predicting and Preventing the Risk of Heart Failure Among Adults With Diabetes Without Atherosclerotic Cardiovascular Disease: A Pooled Cohort Analysis.
Patel KV; Segar MW; Klonoff DC; Khan MS; Usman MS; Lam CSP; Verma S; DeFilippis AP; Nasir K; Bakker SJL; Westenbrink BD; Dullaart RPF; Butler J; Vaduganathan M; Pandey A
Circulation; 2024 Jan; 149(4):293-304. PubMed ID: 37950893
[TBL] [Abstract][Full Text] [Related]
12. Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing.
deFilippi CR; Christenson RH; Gottdiener JS; Kop WJ; Seliger SL
J Am Coll Cardiol; 2010 Feb; 55(5):441-50. PubMed ID: 20117457
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide: Insights From the DAPA-HF Trial.
Butt JH; Adamson C; Docherty KF; de Boer RA; Petrie MC; Inzucchi SE; Kosiborod MN; Maria Langkilde A; Lindholm D; Martinez FA; Bengtsson O; Schou M; O'Meara E; Ponikowski P; Sabatine MS; Sjöstrand M; Solomon SD; Jhund PS; McMurray JJV; Køber L
Circ Heart Fail; 2021 Dec; 14(12):e008837. PubMed ID: 34802253
[TBL] [Abstract][Full Text] [Related]
14. Differences in NT-proBNP Response and Prognosis in Men and Women With Heart Failure With Reduced Ejection Fraction.
Daubert MA; Yow E; Barnhart HX; Piña IL; Ahmad T; Leifer E; Cooper L; Desvigne-Nickens P; Fiuzat M; Adams K; Ezekowitz J; Whellan DJ; Januzzi JL; O'Connor CM; Felker GM
J Am Heart Assoc; 2021 May; 10(10):e019712. PubMed ID: 33955231
[TBL] [Abstract][Full Text] [Related]
15. Racial Differences in Natriuretic Peptide Levels: The Dallas Heart Study.
Gupta DK; de Lemos JA; Ayers CR; Berry JD; Wang TJ
JACC Heart Fail; 2015 Jul; 3(7):513-519. PubMed ID: 26071618
[TBL] [Abstract][Full Text] [Related]
16. Prediction of incident heart failure by serum amino-terminal pro-B-type natriuretic peptide level in a community-based cohort.
Campbell DJ; Gong FF; Jelinek MV; Castro JM; Coller JM; McGrady M; Boffa U; Shiel L; Wang BH; Liew D; Wolfe R; Stewart S; Owen AJ; Krum H; Reid CM; Prior DL
Eur J Heart Fail; 2019 Apr; 21(4):449-459. PubMed ID: 30656792
[TBL] [Abstract][Full Text] [Related]
17. Echocardiography, natriuretic peptides, and risk for incident heart failure in older adults: the Cardiovascular Health Study.
Kalogeropoulos AP; Georgiopoulou VV; deFilippi CR; Gottdiener JS; Butler J;
JACC Cardiovasc Imaging; 2012 Feb; 5(2):131-40. PubMed ID: 22340818
[TBL] [Abstract][Full Text] [Related]
18. Race-based demographic, anthropometric and clinical correlates of N-terminal-pro B-type natriuretic peptide.
Patel N; Gutiérrez OM; Arora G; Howard G; Howard VJ; Judd SE; Prabhu SD; Levitan EB; Cushman M; Arora P
Int J Cardiol; 2019 Jul; 286():145-151. PubMed ID: 30878238
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.
Kristensen SL; Jhund PS; Mogensen UM; Rørth R; Abraham WT; Desai A; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV;
Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29018174
[TBL] [Abstract][Full Text] [Related]
20. Association of Left Atrial Structure and Function With Heart Failure in Older Adults.
Inciardi RM; Claggett B; Minamisawa M; Shin SH; Selvaraj S; Gonçalves A; Wang W; Kitzman D; Matsushita K; Prasad NG; Su J; Skali H; Shah AM; Chen LY; Solomon SD
J Am Coll Cardiol; 2022 Apr; 79(16):1549-1561. PubMed ID: 35450571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]